Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Not Applicable

Terminated

• Conditions: Stroke

• Registration Number: NCT02948140
• Lead Sponsor: Hopital Foch

Brief Summary

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal scanner in the detection of subdiaphragmatic infarction associated to the atrial fibrillation in the cerebral infarction.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-06-13
• Study First Submitted: 2016-10-18
• Study First Submitted QC: 2016-10-26
• Study First Posted: 2016-10-28
• Primary Completion: 2020-12
• Study Completion: 2020-12
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-11
• Last Update Posted: 2021-02-15

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

• Patient over 18
• Patient having a CHADS-VAsc Score ≥ 2;
• Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days;
• Patient affiliated to a national insurance scheme or beneficiary
• Patient having given a written consent

Exclusion Criteria

• Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER).
• Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip).
• Contraindication in injected scanner.
• Current pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Number of patients with subdiaphragmatic infarctions detected by abdominal MRI	14 days

Secondary Outcome Measures

Name	Time	Method
Number of patients with subdiaphragmatic infarctions detected by abdominal scanner	14 days

Trial Locations

Locations (1)

Hôpital Foch; 🇫🇷 Suresnes, France